H19 Promotes HCC Bone Metastasis Through Reducing Osteoprotegerin Expression in a Protein Phosphatase 1 Catalytic Subunit Alpha/p38 Mitogen‐Activated Protein Kinase–Dependent Manner and Sponging microRNA 200b‐3p

Zhao Huang, Liang Chu, Junnan Liang, Xiaolong Tan, Yu Wang, Jingyuan Wen, Jin Chen, Yu Wu, Sha Liu, Jingyu Liao, Rui Hou, Zeyang Ding, Zhanguo Zhang, Huifang Liang, Shasha Song, Caihong Yang, Jinming Zhang, Tao Guo, Xiaoping Chen, Bixiang Zhang – 6 December 2020

Early Allograft Dysfunction Increases Hospital Associated Costs After Liver Transplantation—A Propensity Score–Matched Analysis

Simon Moosburner, Igor M. Sauer, Frank Förster, Thomas Winklmann, Joseph Maria George Vernon Gassner, Paul V. Ritschl, Robert Öllinger, Johann Pratschke, Nathanael Raschzok – 5 December 2020 – Concepts to ameliorate the continued mismatch between demand for liver allografts and supply include the acceptance of allografts that meet extended donor criteria (ECD). ECD grafts are generally associated with an increased rate of complications such as early allograft dysfunction (EAD).

Platelets Stimulate Liver Regeneration in a Rat Model of Partial Liver Transplantation

Chen Liang, Kazuhiro Takahashi, Kinji Furuya, Tatsuya Oda, Nobuhiro Ohkohchi – 4 December 2020 – Living donor liver transplantation (LDLT) is sometimes associated with impaired regeneration and severe ischemia/reperfusion injury (IRI) in the graft, resulting in small‐for‐size syndrome (SFSS). Platelets were previously reported to stimulate liver regeneration in models of hepatectomy, but the evidence in partial liver transplantation (LT) is lacking.

LiverLearning®: 2020 Webinar: Chronic Hepatitis C 500: The Advanced Course

Many HCV-infected patients suffer from decompensated cirrhosis. Aside from appropriate care of their cirrhosis, these patients may benefit from therapy, irrespective of liver transplant candidacy. Providers outside of transplant centers, should be knowledgeable about pertinent aspects of liver transplants for their patients. Finally, several groups have reported unusual genotype subtypes which are less responsive to existing DAA regimens. This webinar is designed for the experienced HCV-treatment provider.Brian Pearlman Brian L.

Molecular Profiling of Decompensated Cirrhosis by a Novel MicroRNA Signature

Ana Garcia Garcia de Paredes, Nicolo Manicardi, Luis Tellez, Luis Ibañez, Felix Royo, Javier Bermejo, Carolina Blanco, Constantino Fondevila, Val Fernandez Lanza, Laura Garcia‐Bermejo, Juan Manuel Falcon‐Perez, Rafael Bañares, Jordi Gracia‐Sancho, Agustin Albillos – 2 December 2020 – Noninvasive staging of decompensated cirrhosis is an unmet clinical need. The aims of this study were to characterize and validate a novel microRNA (miRNA) signature to stage decompensated cirrhosis and predict the portal pressure and systolic cardiac response to nonselective beta‐blockers (NSBBs).

Subscribe to